Few in our industry would disagree with MIT’s Technology Review characterization of CRISPR/Cas9 as “the biggest biotech discovery of the century.” And yesterday’s revelation that Chinese scientists have already edited the genomes of human embryos has touched off yet another ethical debate as well as warnings that the findings show the technology is simply not […]
In March 2015, BioInformatics released the third title on its cloud-based analytics platform, Interactive Market Intelligence. The Market for Stem Cell Research Products, a quantitative and primary research analysis, is now accessible online. Here’s what you can expect to learn: The market size, share and growth by region, industry segment and product category The drivers influencing brand […]
When we first started in the market research business we viewed ourselves primarily as a publisher of market research. We developed our off-the-shelf reports largely from quantitative surveys of scientific customers rather than from secondary sources as others were doing. Twenty years ago we were using postal mail surveys (remember those?). When we moved our […]
Pay Invoice
Latest Blogs
-
Assessing the Value of Product Attributes: Deciphering Consumer Preferences
April 25, 2024 10:28 am
-
How Market Research Supercharges Life Sciences Go-To-Market Strategies
April 24, 2024 12:34 pm
-
4 Key Components to a Winning Go-To-Market Strategy
April 24, 2024 12:28 pm
Sitemap
Your Data and Privacy
About Us
BioInformatics, part of the Science and Medicine Group, is the leading research and advisory firm serving the life science and diagnostic industries. Our expertise includes primary quantitative and qualitative research in addition to secondary research and published reports. We own a proprietary, international community of more than 55,000 scientists and biomedical researchers to provide insights that grow businesses and move markets. Our multi-disciplinary team is comprised of industry veterans, market research experts, and survey statisticians.